MS is on the Global Increase

Get the Report Here

The global prevalence of MS is estimated at 36 people per
100,000 people, which means there are 2.8 million people
living with MS worldwide.

This equates to 1 in every 3,000 people living with the disease.

This global estimate has increased from 2.3 million
people in 2013, which is consistent with stated increases
in national prevalence in some countries
over this time.

UK is no longer MS Central

About the author



  • A very interesting map. Thank you for posting! Is there any way that it can be seen larger? It looks like The Netherlands, where I live, now has a higher number of people with MS than the UK. I can’t zoom in to check, however.

  • Thanks so much for this. Is there any way I could get in touch with Clare Walton from MSIF – as I wanted to see if there was any ethnic/race breakdown MSIF might have?
    Best, Rachel (Horne)

  • Multiple sclerosis incidence and
    prevalence in Ukraine over the last two

    Background and aims: Multiple sclerosis (MS)
    epidemiological trends are a matter of a special attention
    due to a growing significance of this disease, so the aim was
    to reveal such trends in Ukraine.
    Methods: Data of the official general and public health
    statistics on regions of Ukraine since 2000 were examined
    and used for the calculations.
    Results: In 2000, the MS prevalence in Ukraine was 35.63
    cases per 100,000 (middle-risk area) (Figure 1), but 5
    regions were in a MS high-risk area (50-100 cases per
    100,000) (Figure 2A). Ten years later, MS prevalence in
    Ukraine has grown to 42.29 per 100,000 and 19 (70.1%)
    regions of 27 ones were in the MS high-risk area (Figure
    2B). In 2017, overall MS prevalence in Ukraine approached
    to a high-risk threshold (49.16 per 100,000). During the last
    two decades in Ukraine, with an average MS incidence of
    2.60±0.18 cases per 100,000, there is an upward trend in
    MS prevalence for Western and Central regions (Figure
    2C). Medical check-up had risen from 83.9% to 92.0% in
    this period.

    Conclusion: An increasing of MS prevalence and incidence
    in 2000-2010 was partly due to improvement of diagnostic
    tools and physicians’ vigilance concerning MS diagnosis. A
    slower-than-expected according to MS incidence growth of
    MS prevalence in Ukraine resulted from migration
    processes first of all. It should be taking into account also
    that the statistical data since 2014 were under influence of
    a number of factors not related to MS, particularly
    sociopolitical ones.

By MouseDoctor



Recent Posts

Recent Comments